| For: | Liu ZP, Ouyang GQ, Huang GZ, Wei J, Dai L, He SQ, Yuan GD. Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990-2019. World J Hepatol 2023; 15(11): 1210-1225 [PMID: 38075011 DOI: 10.4254/wjh.v15.i11.1210] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v15/i11/1210.htm |
| Number | Citing Articles |
| 1 |
Tianqi Duo, Yun Wen, Yu Bian, Yizheng Wang, Xiaofang Zhang, Jin Ju, Yanjie Lu, Zhiguo Wang, Jinghao Wang, Baofeng Yang. Rising burden of MASLD and CKM syndrome in Asia: A decade of trends and future projections. Metabolism 2026; 178 doi: 10.1016/j.metabol.2026.156549
|
| 2 |
Ji Li, Yifeng Cheng, Yongli Pan, Xue Liu, Xiaoying Gan, Xiaoqing Pan, Yali Chen. The Economic Impact of Cirrhosis and Other Chronic Liver Diseases on Global, Regional, and National Economies. Clinical and Translational Gastroenterology 2026; doi: 10.14309/ctg.0000000000000989
|
| 3 |
Israel Rico-Alba, Alberto Retana-Guzmán, Marcela Agudelo-Botero, Claudio Alberto Dávila-Cervantes. Trends of metabolic dysfunction-associated steatotic liver disease in Mexico, 1990–2023: insights from the Global Burden of Disease Study. Annals of Hepatology 2026; doi: 10.1016/j.aohep.2026.102224
|
| 4 |
Hui Wu, Zi-Heng Zhang, Ting Ye, Jia-Ni Chen, Tao-Hsin Tung, Jian-Sheng Zhu. Efficacy and safety of GLP-1 receptor agonists in patients with metabolic-associated fatty liver diseases: an umbrella review. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1783429
|
| 5 |
Zhigang Xu, Baohong Xu. Nonlinear association between AST/ALT ratio and 28-day all-cause mortality following ICU admission in critically ill cirrhotic patients: a retrospective cohort study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03966-0
|
| 6 |
Lu Wang, Zigong Shao, Xiaobei Wang, Wenqiu Lu, Hong Sun. Xenobiotic-induced liver injury: Molecular mechanisms and disease progression. Ecotoxicology and Environmental Safety 2025; 303 doi: 10.1016/j.ecoenv.2025.118854
|
| 7 |
Shiying Ruan, Liyuan Huang, Jie Song, Zusong Yi, Weipeng Sun, Fankun Zhou, Chang Feng, Guihua Du, Jie Xie, Yuanan Lu, Guangqin Fan. Global burden trends and forecasts for MAFLD in adolescents and young adults from 1990 to 2021. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-98489-9
|
| 8 |
M. N. Adam, C. O. Essumang, N. K.-A. Quartey, C. A. Ofosu, F. K. Saalia, W. O. Ellis, I. W. Ofosu. Systematic quantitative data synthesis of dietary aflatoxin-induced hepatocellular carcinoma in Ghana and Nigeria. Food Safety and Risk 2026; 13(1) doi: 10.1186/s40550-026-00145-1
|
| 9 |
Yasser Fouad, Alaa M. Mostafa, Safaa M. Abdelhalim, Alshymaa A. Hassanine, Enas Kamal, Ebada Mohamed Said, Doaa Elwazzan, Nadia Abdelaaty Abdelkader, Mohammed Eslam. Dietary recommendations for patients with chronic liver diseases: the need for increased awareness among non-hepatologist physicians. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-04685-w
|
| 10 |
Risi Chen, Ying Zeng, Yining Li, Linzhe Hung, Meixin Min, Ke Xu, Jia Wang, Tingting Liu, Dan Deng, Chongyang Qin, Jinze Ma, Qiang Luo, Xiaoping Xiao. 1‐Naphthol Drives Liver Steatosis and Fibrosis via the CA3‐CD36 Axis Independent of Obesity. The FASEB Journal 2026; 40(11) doi: 10.1096/fj.202504464R
|
| 11 |
Xuangao Wu, Ting Zhang, Sunmin Park. Dietary quality, perceived health, and psychological status as key risk factors for newly developed metabolic dysfunction–associated steatotic liver disease in a longitudinal study. Nutrition 2025; 130 doi: 10.1016/j.nut.2024.112604
|
| 12 |
Detection of Liver Cirrhosis using a Web-Based Convolutional Neural Network System<b></b>. International Journal of Scientific Research in Computer Science, Engineering and Information Technology 2025; 11(4) doi: 10.32628/CSEIT25113395
|